INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
Report Outlook
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 11.29 billion by 2029 | 12.5 % | North America |
| By Services | By Technology | By Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Immuno Oncology Assays Market Overview
The global immuno oncology assays market is projected to reach USD 11.29 billion by 2029 from USD 3.91 billion in 2020, at a CAGR of 12.5 % from 2020 to 2029.
The immuno-oncology assay represents a category of immunoassays predominantly employed in the diagnosis of cancer. It involves the simultaneous detection and quantification of various analytes, such as proteins, biomolecules, growth factors, cytokines, and chemokines, profiling them to harness the body’s innate defense system to target and eradicate cancer cells. This assay serves as a pivotal tool in in vitro analysis, facilitating the exploration of dynamic interactions between cancer cells and immune cells, the intricate tumor microenvironment, and the discernment of immunoreactivity across a spectrum of cell-based assays to anticipate mode of action and pharmacodynamics.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Services, By Technology, By Application, By Region |
| By Services |
|
| By Technology | |
| By Application |
|
| By Region |
|
Furthermore, the immuno-oncology assay exhibits substantial promise in the research and development of pharmaceuticals for the treatment of ailments like cancer and cardiovascular diseases. For example, the xMAP multiplex assay platform offers a venue for cancer biomarker assays, compatible with diverse biological samples including plasma, serum, and cultured cells. Spearheaded by the American Association of Cancer Research (AACR), the development of multiplex immunoassays has facilitated the scrutiny of acquired resistance to receptor tyrosine kinase (RTK) inhibitors, pivotal targets in cancer drug development endeavors.
The immuno-oncology assay market is experiencing notable expansion, propelled by the surge in research and development initiatives within the pharmaceutical sector aimed at combating cancer. These assays play a pivotal role in clinical trials by reducing research costs and manual labor while enhancing experimental and therapeutic efficacy. Moreover, they enable precise comprehension of a compound’s response, mirroring the tumor microenvironment. Optimized cell-based assays furnish vital insights to validate the efficacy of drugs or compounds through simple and progressively intricate co-culture assays. Additionally, they offer streamlined and expedited cancer analysis, leveraging automation compared to conventional methodologies, thus catalyzing growth in the immuno-oncology assay market.
Immuno Oncology Assays Market Segment Analysis
The global immuno oncology assay market is segmented based on services, technology, application. By services, the market is bifurcated into consumables, instruments, software services. The consumables segment was the greatest contributor to the immuno-oncology tests market. The demand for consumables in vast quantities, as opposed to instruments, is the primary driver of this segment’s growth. Due to the use of various types of reagents, kits, and instruments for completing the tests, the market is expected to stay stable over the forecast period. During the projected period, however, the software segment is expected to increase at the quickest rate.
By technology, the market is divided into PCR, immunoassay, NGS, ISH, flow cytometry. The PCR sector held the most market share. This category is developing due to the increasing usage of PCR in immuno-oncology biomarker identification and discovery studies. This is due to the widespread use of polymerase chain reaction (PCR) in oncology diagnosis and research. Furthermore, technological improvements in PCR technology, such as the introduction of real-time PCR, contribute to the segment’s growth.
By application, the market is segmented into research, diagnostics. The market for immuno-oncology tests was dominated by the research applications sector. The growing importance of biomarker-based medication development is propelling this segment forward. Research applications accounted for a larger portion of the market. It’s because biomarker-based drug development has become popular.
Immuno Oncology Assays Market Players
The immuno oncology assays market key players include Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd.
For corporate expansion, these key leaders are implementing strategic formulations such as new product development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending in product development, which is fueling revenue generation.
Who Should Buy? Or Key Stakeholders
- Medical Technology Companies
- Scientific Research & Development
- Medical Devices Manufacturers
- End-users
- Regulatory Authorities
- Others
Key Takeaways:
- The global immuno-oncology assays market is projected to grow at a CAGR of 12.5%.
- By technology, the PCR sector held the most market share.
- By application, the market for immuno-oncology tests was dominated by the research applications sector.
- North America is expected to lead the market.
- The immuno-oncology assays market is witnessing rapid growth driven by increasing research activities and the development of novel cancer immunotherapies.
Immuno Oncology Assays Market Regional Analysis
The immuno oncology assays market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- Latin America: includes Brazil, Argentina and Mexico
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Throughout the projected period, North America is expected to lead the market. The market’s huge share is attributed to factors such as the existence of key companies, the high prevalence of cancer in the region, and established healthcare infrastructure. Additionally, favorable government efforts and an increase in the number of research partnerships are likely to boost market expansion. Because of favorable healthcare regulations, a large patient population, and a developed healthcare sector, the United States has the largest share in this region.
Key Market Segments: Immuno Oncology Assays Market
Immuno Oncology Assays Market By Services, 2020-2029, (USD Billion)
- Consumables
- Instruments
- Software Services
Immuno Oncology Assays Market By Technology, 2020-2029, (USD Billion)
- PCR
- Immunoassay
- NGS
- ISH
- Flow Cytometry
Immuno Oncology Assays Market By Application, 2020-2029, (USD Billion)
- Research
- Diagnostics
Immuno Oncology Assays Market By Region, 2020-2029, (USD Billion)
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Key Question Answered
- What is the current size of the immuno oncology assays market?
- What are the key factors influencing the growth of immuno oncology assays?
- What are the major applications for immuno oncology assays?
- Who are the major key players in the immuno oncology assays market?
- Which region will provide more business opportunities for immuno oncology assays in future?
- Which segment holds the maximum share of the immuno oncology assays market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Immuno Oncology Assays Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Immuno Oncology Assays Market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global Immuno Oncology Assays Market Outlook
- Global Immuno Oncology Assays Market by Services, 2020-2029, (USD MILLION)
- Consumables
- Instruments
- Software Services
- Global Immuno Oncology Assays Market by Technology, 2020-2029, (USD MILLION)
- PCR
- Immunoassay
- NGS
- ISH
- Flow Cytometry
- Global Immuno Oncology Assays Market by Application, 2020-2029, (USD MILLION)
- Research
- Diagnostics
- Global Immuno Oncology Assays Market by Region, 2020-2029, (USD MILLION)
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
- Luminex Corporation
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Becton, Dickinson and Company
- Abcam PLC
- Seegene Inc.
- Meso Scale Diagnostics LLC
- Randox Laboratories Ltd  *The Company List Is Indicative
LIST OF TABLES
TABLE 1 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS)2020-2029
TABLE 2 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 3 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 4 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 5 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 6 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 7 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 8 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 9 Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â UK IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â UK IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â UK IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UAE IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â UAE IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â UAE IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY SERVICES, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY TECHNOLOGY, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL IMMUNO ONCOLOGY ASSAY MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â NORTH AMERICA IMMUNO ONCOLOGY ASSAY MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â Â Â Â EUROPE IMMUNO ONCOLOGY ASSAY MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA IMMUNO ONCOLOGY ASSAY MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC IMMUNO ONCOLOGY ASSAY MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â MIDDLE EAST ASIA AND AFRICA IMMUNO ONCOLOGY ASSAY MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 19Â Â Â Â Â Â Â Â Â Â LUMINEX CORPORATION: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â ILLUMINA INC.: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â ABCAM PLC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â SEEGENE INC.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â MESO SCALE DIAGNOSTICS LLC: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â RANDOX LABORATORIES LTD: COMPANY SNAPSHOT
FAQ
The immuno oncology assays market size had crossed USD 3.91 Billion in 2020 and will observe a CAGR of more than 12.5 % up to 2029 driven by the expanding need for personalized medicine, the rising prevalence of cancer and the growing acceptance of targeted therapy, and the growing importance of companion diagnostics in drug development
North America held more than 32% of the immuno oncology assays market revenue share in 2020 and will witness expansion with the existence of key companies, the high prevalence of cancer in the region, and established healthcare infrastructure. Additionally, favorable government efforts and an increase in the number of research partnerships.
The upcoming trends in immuno oncology assays market is introduction of multiplex assays.
The research applications sector dominated immuno-oncology tests. This category is moving forward due to the increased importance of biomarker-based pharmaceutical development. A higher portion of the market was devoted to research applications. It’s due to the growing popularity of biomarker-based drug development.
The market is projected to be led by North America. The market’s massive size may be ascribed to a number of reasons, including the presence of important firms, the region’s high cancer prevalence, and well-established healthcare infrastructure. Likewise, favorable government initiatives and an increase in the number of research partnerships are expected to promote market growth.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.